Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced the appointment of three key executives in high priority strategic roles integral to the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE